NCT06680037 2026-05-18A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersTG Therapeutics, Inc.Phase 1 Recruiting100 enrolled
NCT06312644 2026-04-16Study of UltomirisĀ® (Ravulizumab) Safety in PregnancyAlexion Pharmaceuticals, Inc.Recruiting75 enrolled